QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
The data have finally arrived!
Are you interested in studying liver diseases? Our research platform “Health Outcomes and Risk Assessment in Chronic Liver Disease” (HERALD) constitutes a unique blend of data on healthcare visits in primary and specialty care, prescriptions, lab values, FibroScan data, information on cancer, quality of care data on diabetes, socioeconomics, migration, and cause of death for 864,077 patients recorded with a diagnosis of chronic liver disease (CLD) in the Stockholm […]
The Convini Relay Race in Stockholm
Whats your 5k PB? Last week members of our Stockholm office participated in Convinistafetten, Swedens biggest relay race. Our teams Quantifly, Quantimax and Quantifast flew past the beautiful scenery of Djurgården, and looked this happy afterwards. Well done guys! ?♀️?♂️
Get to know Mathias!
What defines a good day at work for Mathias Lilja, #LeadAnalyst at Quantify in Stockholm? It seems #pingpong and advanced #programming is the perfect kombo. Get to know Mathias a bit more:
https://career2.quantifyresearch.com/pages/meet-mathias
Persistence With Biologic Treatments in Psoriasis
Does it matter whether you use a clinical registry or administrative database to calculate drug persistence rates?
The answer is yes! Colleagues from The Janssen Pharmaceutical Companies of Johnson & Johnson, Quantify Research and our CEO Kirk Geale recently published a literature review in the Journal of Drugs in Dermatology (JDD) examining the systematic differences in biologic drug persistence rates when […]